Summary
51 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 19% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for £2.15B in the last fiscal year, 5.2% of its market value.
- It has raised its dividend 5 years in a row.
What to watch
- Revenue growth is slowing: 6.3% a year over the last 3 years against 36% over 5 years.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 33.1 GBP for 1 GBP of yearly profit. Over the last five years it was 49.7 GBP on average.
Valuation in detailIs it growing?
SlowlyRevenue (GBP)
Diluted EPS (GBP)
- Analyst estimate
Revenue grew by 36% a year over 5 years. Over the last 3 years it grew by 6.3% a year. For the next fiscal year analysts expect revenue to grow by 4.4%. Earnings per share grew by 19% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.48%
- Paid out of profit
- 82%
- Raised in a row
- 5 years
You receive $2.79 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.